Loading…
Stallion India Fluorochemicals (STALLION)₹200.59−2.55%Industrial Gases
In the Mar 2026 quarter (standalone), Stallion India Fluorochemicals reported sales of ₹110 Cr, down 27.7% from Mar 2025, and net profit of ₹11.01 Cr, down 15.2% year on year. For the year to Mar 2026, sales were ₹430 Cr and net profit ₹44.02 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 72.79 | 67.82 | 84.81 | 152 | 110 | 106 | 105 | 110 |
| Expenses | 60.92 | 65.90 | 70.83 | 133 | 95.78 | 89.88 | 92.78 | 93.80 |
| Operating Profit | 11.96 | 1.99 | 13.94 | 18.93 | 13.96 | 15.94 | 11.97 | 15.95 |
| OPM % | 17.1% | 2.9% | 17.0% | 12.1% | 13.1% | 15.0% | 11.1% | 15.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 2.01 | 0.99 |
| Interest | 0.99 | 1.99 | 1.99 | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Profit before tax | 11.02 | 1.01 | 12.02 | 18.03 | 14.02 | 15.03 | 13.02 | 17.04 |
| Tax % | 26.0% | −56.0% | 20.0% | 27.0% | 25.0% | 25.0% | 16.0% | 34.0% |
| Net Profit | 7.99 | 0.99 | 10.01 | 12.99 | 9.99 | 10.99 | 11.01 | 11.01 |
| EPS (Rs) | 0.95 | 0.10 | 1.10 | 1.15 | 0.90 | 0.99 | 0.97 | 0.95 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 118 | 185 | 225 | 232 | 376 | 430 | 430 |
| Expenses | 104 | 153 | 208 | 209 | 329 | 372 | 372 |
| Operating Profit | 13.95 | 32.89 | 17.93 | 23.93 | 47.83 | 57.83 | 57.82 |
| OPM % | 12.0% | 18.0% | 8.0% | 10.0% | 13.1% | 13.0% | 13.5% |
| Other Income | 1.01 | 0.00 | −2.01 | 2.99 | 2.01 | 2.99 | 3.00 |
| Interest | 0.00 | 0.99 | 0.99 | 3.99 | 5.98 | 0.99 | 0.00 |
| Depreciation | 0.99 | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Profit before tax | 13.03 | 30.04 | 13.03 | 22.04 | 42.07 | 59.13 | 59.11 |
| Tax % | 27.0% | 29.9% | 25.0% | 28.0% | 24.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | −1.78 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 9.99 | 21.01 | 9.99 | 15.01 | 31.99 | 44.02 | 43.00 |
| EPS (Rs) | 5.52 | 11.82 | 1.22 | 1.73 | 2.79 | 3.79 | 3.81 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 11.96 | 11.97 | 54.84 | 60.89 | 78.96 | 116 |
| Reserves | 27.89 | 48.87 | 15.96 | 63.86 | 222 | 564 |
| Borrowings | 10.01 | 2.01 | 18.01 | 65.01 | 2.01 | 34.05 |
| Other Liabilities | 104 | 34.98 | 37.12 | 9.04 | 30.14 | 22.11 |
| Total Liabilities | 153 | 97.83 | 126 | 200 | 334 | 736 |
| Fixed Assets | 18.93 | 17.92 | 12.95 | 13.95 | 16.93 | 30.87 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.96 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 134 | 79.91 | 113 | 186 | 316 | 670 |
| Inventories | 31.91 | 42.82 | 41.83 | 90.71 | 101 | 127 |
| Trade receivables | 91.01 | 27.97 | 41.97 | 70.98 | 106 | 77.97 |
| Cash & equivalents | 2.99 | 2.01 | 15.01 | 17.01 | 75.09 | 434 |
| Total Assets | 153 | 97.83 | 126 | 200 | 334 | 736 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | −7.97 | 7.98 | −2.99 | −72.81 | −12.96 | 38.85 |
| Cash from investing activity | −2.01 | −1.01 | −13.01 | 12.01 | −19.99 | −253 |
| Cash from financing activity | 11.98 | −7.99 | 15.98 | 75.86 | 75.93 | 366 |
| Net cash flow | 1.99 | −0.99 | −0.99 | 14.97 | 42.93 | 154 |
| Capex | 1.01 | 1.01 | 0.00 | 2.01 | 5.01 | 49.04 |
| Free cash flow | −9.98 | 6.99 | −2.99 | −74.91 | −17.98 | −9.98 |
| CFO / OP % | −32.0% | 44.0% | 43.1% | −287.0% | 5.0% | 108.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 282 | 56 | 69 | 111 | 102 | 66 |
| Inventory days | 127 | 112 | 79 | 177 | 127 | 133 |
| Days payable | 394 | 76 | 46 | 7 | 27 | 19 |
| Cash conversion cycle | 15 | 92 | 102 | 281 | 202 | 179 |
| Working capital days | 56 | 81 | 61 | 146 | 192 | 144 |
| ROCE % | — | 55.0% | 22.0% | 18.0% | 20.0% | 12.0% |
For the Mar 2026 quarter, Stallion India Fluorochemicals reported sales of ₹110 Cr, down 27.7% year on year and net profit of ₹11.01 Cr, down 15.2% year on year. The operating margin was 15.0%.
Stallion India Fluorochemicals' sales for the year to Mar 2026 were ₹430 Cr; over the last twelve months they were ₹430 Cr.
Net profit for the year to Mar 2026 was ₹44.02 Cr, and ₹43 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.81.
Stallion India Fluorochemicals reported borrowings of ₹34.05 Cr at Mar 2026, against cash and equivalents of ₹434 Cr.
Cash from operations was ₹38.85 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹9.98 Cr.